SlideShare uma empresa Scribd logo
1 de 12
LUPUS ERYTHEMATOSUS Done by : AbdulrahmanSulaiman  Al-Otaiq
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) Autoimmune disease affecting multiple organ systems Relapsing (flares) and remitting course Protean clinical manifestations Etiology is unknown Female to male ratio is 9:1 Age of onset 16 to 55 years (65%)  < 16 years (20%)  > 55 years (15%)
pathogenesis Genetic susceptibility  involvement of  human leucocyte antigen (HLA) class II gene polymorphisms.       presence of  anti-small nuclear ribonuclear protein, anti-nuclear ribonuclear protein and anti-DNA antibodies. hormones Increase in estrogen  lead to ↑B cell differentiation & ↓In vitro apoptosis of PBMCs &↓TNF production,        This will leads to B cell hyperactivity and the production of pathogenic autoantibodies. Disturbances of the immune response Environmental antigens and self antigens are taken up by  antigen presenting cells (APCs). process the antigens into peptides & present them to T cells through their surface HLA molecules.  The activated T cells in turn stimulate the B cells to produce pathogenic autoantibodies.
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) - PATHOGENESIS Defective regulation of apoptosis Accelerated rate of apoptosis in macrophages mediated (in part) by T cells  T-cell mediated APC apoptosis Defective clearance of apoptotic cells Increased cell death with nuclear antigens exposed Nuclear antigens DS-DNA, Smith, Sjogren’s syndrome A (SSA) and B (SSB) Deposition of autoantibody-nuclear antigen complexes
Main Pathology The plasma cells are producing antibodies that are specific for self proteins, namely ds-DNA Overactive B-cells Suppressed regulatory function in T-cells Lack of T-cells Activation of the Complement system
Overactive B-cells Estrogen is a stimulator of B-cell activity Lupus is much more prevalent in females of ages 15-45 Height of Estrogen production IL-10, also a B-cell stimulator is in high concentration in lupus patient serum.  High concentration linked to cell damage caused by inflammation
T-cell Malfunctions Fc region switch ζ εγ Leads to malfunction in signaling and decreased IL-2 production Increased levels of Ca2+ Leads to spontaneous apoptosis
T-cell Signal Transduction
Activation of Complement System Complement system is activated by the binding of antibodies to foreign debris. In this case its over activation RBCs lack CR1 receptor Decreasing the affective removal of complexes
IgG Pathogen IgG is the most “pathogenic” because it forms intermediate sized complexes that can get to the small places and block them.
DNA is the Main man DNA is the main antigen for which antibodies are formed. Extracellular DNA has an affinity for basement membrane where it is bound by autoantibodies. Classical thickening of the basement membrane
THANK YOU     Reference : Burket's Oral Medicine, chapter 5

Mais conteúdo relacionado

Mais procurados

Systemic Lupus Erythematosus
Systemic Lupus ErythematosusSystemic Lupus Erythematosus
Systemic Lupus Erythematosus
Sheelendra Shakya
 

Mais procurados (20)

Systemic Lupus Erythematosus
Systemic Lupus ErythematosusSystemic Lupus Erythematosus
Systemic Lupus Erythematosus
 
Systemic lupus erythematosus
Systemic lupus erythematosusSystemic lupus erythematosus
Systemic lupus erythematosus
 
SLE Presentation
SLE PresentationSLE Presentation
SLE Presentation
 
Systemic Lupus Erythematous (SLE)
Systemic Lupus Erythematous (SLE)Systemic Lupus Erythematous (SLE)
Systemic Lupus Erythematous (SLE)
 
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
 
Systemic lupus erythematosus.
Systemic lupus erythematosus.Systemic lupus erythematosus.
Systemic lupus erythematosus.
 
Systemic Lupus Erythematosus
Systemic Lupus ErythematosusSystemic Lupus Erythematosus
Systemic Lupus Erythematosus
 
Sle
SleSle
Sle
 
Systemic Lupus Erythematosus
Systemic Lupus ErythematosusSystemic Lupus Erythematosus
Systemic Lupus Erythematosus
 
Systemic lupus erythematosus
Systemic lupus erythematosusSystemic lupus erythematosus
Systemic lupus erythematosus
 
Sle pathophysiology and management
Sle pathophysiology and managementSle pathophysiology and management
Sle pathophysiology and management
 
systemic lupus erythematosus
systemic lupus erythematosussystemic lupus erythematosus
systemic lupus erythematosus
 
Pathogenesis systemic lupus erythematosus by dr bashir ahmed dar associate pr...
Pathogenesis systemic lupus erythematosus by dr bashir ahmed dar associate pr...Pathogenesis systemic lupus erythematosus by dr bashir ahmed dar associate pr...
Pathogenesis systemic lupus erythematosus by dr bashir ahmed dar associate pr...
 
S Lecture
S LectureS Lecture
S Lecture
 
Treatment of Systemic Lupus
Treatment of Systemic LupusTreatment of Systemic Lupus
Treatment of Systemic Lupus
 
Sle
SleSle
Sle
 
systemic lupus erythematosus
systemic lupus erythematosussystemic lupus erythematosus
systemic lupus erythematosus
 
Pediatric systemic lupus erythematosus
Pediatric systemic lupus erythematosusPediatric systemic lupus erythematosus
Pediatric systemic lupus erythematosus
 
Systemic lupus erythematosis
Systemic lupus erythematosisSystemic lupus erythematosis
Systemic lupus erythematosis
 
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE
SYSTEMIC LUPUS ERYTHEMATOSUS (SLESYSTEMIC LUPUS ERYTHEMATOSUS (SLE
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE
 

Destaque

Lupus erythematosus cell
Lupus erythematosus cellLupus erythematosus cell
Lupus erythematosus cell
Govardhan Joshi
 
White lesions(collection)
White lesions(collection)White lesions(collection)
White lesions(collection)
Anhar Al-gebaly
 

Destaque (20)

Lupus erythematosus cell
Lupus erythematosus cellLupus erythematosus cell
Lupus erythematosus cell
 
Le cell
Le cellLe cell
Le cell
 
White lesions ppt
White lesions pptWhite lesions ppt
White lesions ppt
 
Systemic Lupus Erythematosus
Systemic Lupus ErythematosusSystemic Lupus Erythematosus
Systemic Lupus Erythematosus
 
Systemic lupus erythematosus
Systemic lupus erythematosusSystemic lupus erythematosus
Systemic lupus erythematosus
 
SLE
SLESLE
SLE
 
Th6
Th6Th6
Th6
 
Actinic Keratoses: Pre-malignant Skin Tumors
Actinic Keratoses: Pre-malignant Skin TumorsActinic Keratoses: Pre-malignant Skin Tumors
Actinic Keratoses: Pre-malignant Skin Tumors
 
Ua urinalyisisreview
Ua urinalyisisreviewUa urinalyisisreview
Ua urinalyisisreview
 
White& red lesions
White& red lesionsWhite& red lesions
White& red lesions
 
Pigmented actinic keratosis
Pigmented actinic keratosisPigmented actinic keratosis
Pigmented actinic keratosis
 
Oral ulcers
Oral ulcersOral ulcers
Oral ulcers
 
pathology of renal syatem
pathology of renal syatempathology of renal syatem
pathology of renal syatem
 
glomerular disease
glomerular diseaseglomerular disease
glomerular disease
 
Oral ulcer revision 1
Oral ulcer revision 1Oral ulcer revision 1
Oral ulcer revision 1
 
Oral ulcersppt
Oral ulcerspptOral ulcersppt
Oral ulcersppt
 
Whit lesions
Whit lesionsWhit lesions
Whit lesions
 
Pigmentation today
Pigmentation todayPigmentation today
Pigmentation today
 
Types of ulcers
Types of ulcersTypes of ulcers
Types of ulcers
 
White lesions(collection)
White lesions(collection)White lesions(collection)
White lesions(collection)
 

Semelhante a Lupus erythematosus

Immunology vii hla_regulation
Immunology vii hla_regulationImmunology vii hla_regulation
Immunology vii hla_regulation
MUBOSScz
 
Immunodeficieny states lecture notes
Immunodeficieny states lecture notesImmunodeficieny states lecture notes
Immunodeficieny states lecture notes
Bruno Mmassy
 
primary defect in antibody production.pptx
primary defect in antibody production.pptxprimary defect in antibody production.pptx
primary defect in antibody production.pptx
IraKC
 
Congenital and Acquired Immunodeficiency
Congenital and Acquired ImmunodeficiencyCongenital and Acquired Immunodeficiency
Congenital and Acquired Immunodeficiency
GifteeJRoumi
 

Semelhante a Lupus erythematosus (20)

Immunology vii hla_regulation
Immunology vii hla_regulationImmunology vii hla_regulation
Immunology vii hla_regulation
 
anti nuclear antibody
anti nuclear antibodyanti nuclear antibody
anti nuclear antibody
 
Clinical immunology vinmukil
Clinical immunology vinmukilClinical immunology vinmukil
Clinical immunology vinmukil
 
severe combined immunodeficiency
severe combined immunodeficiencysevere combined immunodeficiency
severe combined immunodeficiency
 
systemic lupus erythematosus
systemic lupus  erythematosussystemic lupus  erythematosus
systemic lupus erythematosus
 
Autoimmunity
AutoimmunityAutoimmunity
Autoimmunity
 
Combined immunodeficiencies (SCID).ppt.
Combined immunodeficiencies (SCID).ppt.Combined immunodeficiencies (SCID).ppt.
Combined immunodeficiencies (SCID).ppt.
 
Autoimmunity
AutoimmunityAutoimmunity
Autoimmunity
 
Immunodeficiency disease by Dr. Rakesh Prasad Sah
Immunodeficiency disease by Dr. Rakesh Prasad SahImmunodeficiency disease by Dr. Rakesh Prasad Sah
Immunodeficiency disease by Dr. Rakesh Prasad Sah
 
Severe combined immunodeficiency - SCID
Severe combined immunodeficiency - SCIDSevere combined immunodeficiency - SCID
Severe combined immunodeficiency - SCID
 
Immunodeficieny states lecture notes
Immunodeficieny states lecture notesImmunodeficieny states lecture notes
Immunodeficieny states lecture notes
 
primary defect in antibody production.pptx
primary defect in antibody production.pptxprimary defect in antibody production.pptx
primary defect in antibody production.pptx
 
Systemic lupus
Systemic lupusSystemic lupus
Systemic lupus
 
CME: Sepsis Pathogenesis – Microbial factors
CME: Sepsis Pathogenesis – Microbial factorsCME: Sepsis Pathogenesis – Microbial factors
CME: Sepsis Pathogenesis – Microbial factors
 
ESSENTIAL IMMUNOLOGY including basics to applied aspects.pptx
ESSENTIAL IMMUNOLOGY including basics to applied aspects.pptxESSENTIAL IMMUNOLOGY including basics to applied aspects.pptx
ESSENTIAL IMMUNOLOGY including basics to applied aspects.pptx
 
Antigens and toxins
Antigens and toxinsAntigens and toxins
Antigens and toxins
 
Oncogenic dna virus
Oncogenic dna virus Oncogenic dna virus
Oncogenic dna virus
 
Congenital and Acquired Immunodeficiency
Congenital and Acquired ImmunodeficiencyCongenital and Acquired Immunodeficiency
Congenital and Acquired Immunodeficiency
 
Immuniy, Antigen and Antibody, Hypersensitivity reactions and ocular corelati...
Immuniy, Antigen and Antibody, Hypersensitivity reactions and ocular corelati...Immuniy, Antigen and Antibody, Hypersensitivity reactions and ocular corelati...
Immuniy, Antigen and Antibody, Hypersensitivity reactions and ocular corelati...
 
immunology of pregnancy final.pptx
immunology of pregnancy final.pptximmunology of pregnancy final.pptx
immunology of pregnancy final.pptx
 

Último

Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 

Último (20)

Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptxOn_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 

Lupus erythematosus

  • 1. LUPUS ERYTHEMATOSUS Done by : AbdulrahmanSulaiman Al-Otaiq
  • 2. SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) Autoimmune disease affecting multiple organ systems Relapsing (flares) and remitting course Protean clinical manifestations Etiology is unknown Female to male ratio is 9:1 Age of onset 16 to 55 years (65%) < 16 years (20%) > 55 years (15%)
  • 3. pathogenesis Genetic susceptibility  involvement of human leucocyte antigen (HLA) class II gene polymorphisms. presence of anti-small nuclear ribonuclear protein, anti-nuclear ribonuclear protein and anti-DNA antibodies. hormones Increase in estrogen lead to ↑B cell differentiation & ↓In vitro apoptosis of PBMCs &↓TNF production, This will leads to B cell hyperactivity and the production of pathogenic autoantibodies. Disturbances of the immune response Environmental antigens and self antigens are taken up by antigen presenting cells (APCs). process the antigens into peptides & present them to T cells through their surface HLA molecules.  The activated T cells in turn stimulate the B cells to produce pathogenic autoantibodies.
  • 4. SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) - PATHOGENESIS Defective regulation of apoptosis Accelerated rate of apoptosis in macrophages mediated (in part) by T cells T-cell mediated APC apoptosis Defective clearance of apoptotic cells Increased cell death with nuclear antigens exposed Nuclear antigens DS-DNA, Smith, Sjogren’s syndrome A (SSA) and B (SSB) Deposition of autoantibody-nuclear antigen complexes
  • 5. Main Pathology The plasma cells are producing antibodies that are specific for self proteins, namely ds-DNA Overactive B-cells Suppressed regulatory function in T-cells Lack of T-cells Activation of the Complement system
  • 6. Overactive B-cells Estrogen is a stimulator of B-cell activity Lupus is much more prevalent in females of ages 15-45 Height of Estrogen production IL-10, also a B-cell stimulator is in high concentration in lupus patient serum. High concentration linked to cell damage caused by inflammation
  • 7. T-cell Malfunctions Fc region switch ζ εγ Leads to malfunction in signaling and decreased IL-2 production Increased levels of Ca2+ Leads to spontaneous apoptosis
  • 9. Activation of Complement System Complement system is activated by the binding of antibodies to foreign debris. In this case its over activation RBCs lack CR1 receptor Decreasing the affective removal of complexes
  • 10. IgG Pathogen IgG is the most “pathogenic” because it forms intermediate sized complexes that can get to the small places and block them.
  • 11. DNA is the Main man DNA is the main antigen for which antibodies are formed. Extracellular DNA has an affinity for basement membrane where it is bound by autoantibodies. Classical thickening of the basement membrane
  • 12. THANK YOU Reference : Burket's Oral Medicine, chapter 5